Tower Research Capital LLC (TRC) - BETTER THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BETTER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,370
+61.5%
22,868
+376.5%
0.00%
Q2 2023$5,183
+86283.3%
4,799
-47.5%
0.00%
Q1 2023$6
-14.3%
9,146
+40.5%
0.00%
Q4 2022$7
-99.9%
6,510
-5.5%
0.00%
Q3 2022$12,000
-47.8%
6,891
-52.9%
0.00%
-100.0%
Q2 2022$23,00014,627
+7721.9%
0.00%
Q1 2022$0
-100.0%
187
-95.2%
0.00%
Q4 2021$18,0003,9130.00%
Other shareholders
BETTER THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SECTORAL ASSET MANAGEMENT INC 973,833$4,528,0000.68%
Monashee Investment Management LLC 217,900$1,013,0000.25%
Blue Water Life Science Advisors, LP 100,000$465,0000.14%
FARALLON CAPITAL MANAGEMENT LLC 1,350,000$6,278,0000.03%
Alyeska Investment Group, L.P. 344,170$1,600,0000.02%
TWO SIGMA ADVISERS, LP 58,100$270,0000.00%
TWO SIGMA INVESTMENTS, LP 124,749$580,0000.00%
UBS Group AG 2,969$14,0000.00%
WELLS FARGO & COMPANY/MN 59$00.00%
NORTHERN TRUST CORP 16,703$78,0000.00%
View complete list of BETTER THERAPEUTICS INC shareholders